Overview
Hirohisa Ogawa practices in Tokushima, Japan. Ogawa is rated as an Advanced expert by MediFind in the treatment of Pulmonary Fibrosis. Their top areas of expertise are Nonalcoholic Steatohepatitis (NASH), Pulmonary Fibrosis, Metabolic Syndrome, Primary Lateral Sclerosis, and Gastrostomy.
Their clinical research consists of co-authoring 57 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 12 articles in the study of Pulmonary Fibrosis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Nonalcoholic Steatohepatitis (NASH)
- Pulmonary FibrosisOgawa isAdvanced. Learn about Pulmonary Fibrosis.
- Experienced
- Abdominal Obesity Metabolic Syndrome
- Acute Interstitial PneumoniaOgawa isExperienced. Learn about Acute Interstitial Pneumonia.
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- AsthmaOgawa isExperienced. Learn about Asthma.
- CholestasisOgawa isExperienced. Learn about Cholestasis.
- CirrhosisOgawa isExperienced. Learn about Cirrhosis.